Finance ❯ Investments ❯ Stock Market ❯ Public Companies

Shareholder Losses

Multiple Firms Seek Lead Role in Gossamer Bio Securities Suit After PROSERA Miss

Law firms say the company concealed trial‑design and site‑monitoring problems that plaintiffs blame for the failed Phase 3 result and heavy investor losses.

3 ARTICLES

6mo ago

Investor Lawyers Press April Deadlines in Lakeland and Navan Securities Cases

7 ARTICLES

6mo ago

Super Micro Investors Courted to Lead Class Action After DOJ China Server Indictment

6 ARTICLES

6mo ago

Gartner Investors Courted to Lead Securities Class Action as May 18 Deadline Nears

5 ARTICLES

this yr.

Cytokinetics Investors Urged to Act as Lead‑Plaintiff Deadline Nears in REMS‑Related Securities Suit